Rare Disease Contract Research Organization Market Size, Shares, Trends to 2035
The Global Rare Disease Contract Research Organization Market Size was worth around USD 2.15 Billion in 2024 and is Predicted to Grow to around USD 5.06 Billion by 2035 with a Compound Annual Growth Rate (CAGR) of 8.09% from 2025 and 2035. The industry for rare disease contract research organization (CRO) has several opportunities to grow due to an adding emphasis on case-centric, effective, and innovative results in the product trial design to post-marketing, by the top providers similar as IQVIA, Paraxel, Medpace, Labcorp, and technical establishment Ergomed.